Advanced Cardiac Therapies (ACT) Intensive Care Unit Biorepository
Contact
Description
The primary objective of this study is to collect biospecimens to conduct protein biomarker studies in patients with heart failure requiring advanced therapies such as OHT and VAD. A dedicated heart failure biospecimen repository will allow the Cardiac Center to be at the forefront of molecular sub-phenotyping to improve mechanistic understanding, clinical care, and trial design.
Eligibility and criteria
IRB Number:
22-020457
Clinical trial phase:
N/A
Official title:
What to expect
Related specialties
Related conditions
We need families like you
Your time and participation make a difference in supporting the work of the Research Institute and children in our community. Learn more about opportunities to participate in our research.